The neuropsychopharmacological potential of neuroactive steroids

Journal of Psychiatric Research

Volumn 31, Issue 3, 1997, Pages 297-314

  Rupprecht, Rainer ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOSTEROID; ION CHANNEL; PREGNENOLONE SULFATE; PROGESTERONE RECEPTOR; STEROID HORMONE; STEROID RECEPTOR; TETRAHYDRODEOXYCORTICOSTERONE;

CHLORIDE CURRENT; EXCITABILITY; GENE EXPRESSION; HUMAN; OXIDATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SLEEP PATTERN; STEROIDOGENESIS;

EID: 0030821426     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(96)00060-X     Document Type: Article

References (96)

1. Akwa, Y., Young, J., Kabbadj, K., Sancho, M. J., Zucman, D., Vourch, C., Jung-Testas, I., Hu, Z. Y., Le Goascogne, C., Jo, D. H., Corpéchot, C., Simon, P., Baulieu, E. E., & Robel, P. (1991). Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. J. Steroid. Biochem., 40, 71-81.
2. Akwa, Y., Morfin, R. F., Robel, P., & Baulieu, E. E. (1992). Neurosteroid metabolism. 7 alpha-hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem. J., 288, 959-964.
3. Araneo, B., & Daynes, R. (1995). Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endocrinology, 136, 393-401.
4. Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science, 237, 268-275.
5. Ator, N. A., Grant, K. A., Purdy, R. H., Paul, S. M., & Griffiths, R. R. (1993). Drug discrimination analysis of endogenous neuroactive steroids in rats. Eur. J. Pharmacol., 241, 237-243.
6. Barrett-Connor, E., & Edelstein, S. (1994). A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo study. J. Am. Geriatr. Soc., 42, 420-423.
7. Bäckström, T., Zetterlund, B., Blom, S., & Romano, M. (1984). Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand., 69, 240-248.
8. Baulieu, E. E. (1991). Neurosteroids: a new function in the brain. Biol. Cell., 71, 3-10.
9. Belelli, D., Lan, N. C., & Gee, K. W. (1990). Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev., 14, 315-322.
10. A receptor. Brain Res., 561, 157-161.
11. A receptor function. Pharmacol. Biochem. Behav., 45, 423-428.
12. A receptors. J. Neuroendocrinol., 7, 171-177.
13. Bowlby, M. R. (1993). Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol., 43, 813-819.
14. Britton, K. T., Page, M., Baldwin, H., & Koob, G. F. (1991). Anxiolytic activity of the steroid alphaxolone. J. Pharmacol. Exp. Ther., 258, 124-129.
15. Browne, E. S., Porter, J. R., Correa, G., Abadie, J., & Svec, F. (1993). Dehydroepiandrosterone regulation of the hepatic glucocorticoid receptor in the Zucker rat. The obesity research program. J. Steroid Biochem. Molec. Biol., 45, 517-524.
16. Campbell, J. S., & Karavolas, H. J. (1990). Characterization of the purified pituitary cytosolic NADPH:5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductase. J. Steroid Biochem. Molec. Biol., 37, 535-543.
17. Carl, P., Högskilde, S., Nielsen, J. W., Sörensen, M. B., Lindholm, M., Karlen, B., & Bäckström, T. (1990). Pregnanolone emulsion: a preliminary pharmacokinetic and pharmacodynamic study of a new intravenous agent. Anaesthesia, 45, 189-197.
18. Celotti, F., Melcangi, R. C., & Martini, L. (1992). The 5α-reductase in the brain: molecular aspects and relation to brain function. Front. Neuroendocrinol., 13, 163-215.
19. Conneely, O. M., Kettelberger, D. M., Tsai, M. J., Schrader, W. T., & O'Malley, B. W. (1989). The chicken progesterone receptor A and B isoforms are products of an alternate translation event. J. Biol. Chem., 264, 14062-14064.
20. Corpéchot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J. N., Touyer, G., Mouren, M., Prasad, V. V. K., Banner, C., Sjövall, J., Baulieu, E.-E., & Robel, P. (1993). Neurosteroids: 3α-hydroxy-5α-pregnane-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology, 1, 2-6.
21. Costa, E., Auta, J., Guidotti, A., Korneyev, A., & Romeo, E. (1994). The pharmacology of neurosteroidogenesis. J. Steroid Biochem. Molec. Biol., 49, 385-389.
22. Crawley, J. N., Glowa, J. R., Majewska, M. D., & Paul, S. M. (1986). Anxiolytic activity of an endogenous adrenal steroid. Brain Res., 398, 382-385.
23. Denner, L. A., Weigel, N. L., Maxwell, B., Schrader, W. T., & O'Malley, B. W. (1990). Regulation of progesterone receptor-mediated transcription by phosphorylation. Science, 250, 1740-1743.
24. Dennerstein, L., Spencer-Gardner, C., Gotts, G., Brown, J. B., Smith, M. A., & Burrows, G. D. (1980). Progesterone and the premenstrual syndrome: a double blind crossover trial. Br. Med. J., 290, 1617-1621.
25. Evans, R. M. (1988). The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895.
26. Flood, J. F., Baker, M. L., & Davis, J. L. (1990). Modulation of memory processing by glutamic receptor agonists and antagonists. Brain Res., 521, 197-202.
27. Flood, J. F., Morley, J. E., & Roberts, E. (1992). Memory-enhancing effects in male mice of pregnenolone and of steroids metabolically derived from it. Proc. Natl. Acad. Sci. U.S.A., 89, 1567-1571.
28. Flood, J. F., Smith, G. E., & Roberts, E. (1988). Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res., 447, 269-278.
29. Fox, S. R., Harlan, R. E., Shivers, B. D., & Pfaff, D. W. (1990). Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neuroendocrinology, 51, 276-283.
30. Freeman, E. W., Purdy, R. H., Coutifaris, C., Rickels, K., & Paul, S. M. (1993). Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology, 58, 478-484.
31. Friess, E., Trachsel, L., Guldner, J., Schier, T., Steiger, A., & Holsboer, F. (1995). DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am. J. Physiol., 268, E107-E113.
32. Friess, E., Tagaya, H., Trachsel, L., Holsboer, F., & Pupprecht, R. (1997). Progesterone-induced changes in sleep in male subjects. Am. J. Physiol. (in press).
33. A receptor complex modulate pain sensitivity in rats. Brain Res., 643, 194-203.
34. Gee, K. W., Ghang, W. C., Brinton, R. E., & McEwen, B. S. (1987). GABA-dependent modulation of Clionophore by steroids in rat brain. Eur. J. Pharmacol., 136, 419-423.
35. Gee, K. W., Bolger, M. B., Brinton, R. E., Coirini, H., & McEwen, B. S. (1988). Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependance and mechanism of action. J. Pharmacol. Exp. Ther., 246, 803-812.
36. George, M. S., Guidotti, A., Rubinow, D., Pan, B., Mikalauskas, K., & Post, R. M. (1994). CSF neuroactive steroids in affective disorders: pregnenolone, progesterone and DBI. Biol. Psychiatry, 35, 775-780.
37. Grön, G., Friess, E., Herpers, M. & Rupprecht, R. (1997). Assessment of cognitive performance after progesterone administration in healthy male volunteers. Neuropsychobiol. (in press).
38. Harrison, N. L., Majewska, M. D., Harrington, J. W., & Barker, J. L. (1987). Structure-activity relationships for steroid interaction with the gamma-aminobutyric acid A receptor complex. J. Pharmacol. Exp. Ther., 241, 346-353.
39. A receptors by neuroactive steroids. Eur. J. Pharmacol. Mol. Pharmacol. Section, 289, 249-257.
40. A receptors. Biochem. Biophys. Res. Commun., 219, 513-536.
41. Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Thompson, E. B., Rosenfeld, M. G., & Evans, R. M. (1985). Primary structure and expression of a functional glucocorticoid receptor cDNA. Nature, 318, 635-641.
42. Hollenberg, S. M., & Evans, R. M. (1988). Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell, 55, 899-906.
43. Holsboer, F., Spengler, D., & Heuser, I. J. (1992). The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog. Brain Res., 93, 385-417.
44. Jung-Testas, I., Schumacher, M., Robel, P., & Baulieu, E. E. (1994). Actions of steroid hormones and growth factors on glial cells of the central and peripheral nervous system. J. Steroid Biochem. Molec. Biol., 48, 145-154.
45. Karavolas, H. J., & Hodges, D. (1990). Neuroendocrine metabolism of progesterone and related progestins steroids and neuronal activity. Ciba Foundation Symposium, 153, 22-55.
46. Kastner, P., Bocquel, M., Turcotte, B. P., Gamier, J. M., Horwitz, K. B., Chambon, B., Gronemeyer, H. (1990). Transient expression of human and chicken progesterone receptors does not support alternative translation initiation from a single mRNA as the mechanism generating two receptor isoforms. J. Biol. Chem., & 265, 12163-12167.
47. Kokate, T. G., Svensson, B. E., & Rogawski, M. A. (1994). Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther., 270, 1223-1229.
48. Korneyev, A., Pan, B. S., Polo, A., Romeo, E., Guidotti, A., & Costa, E. (1993). Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J. Neurochem., 61, 1515-1524.
49. Krause, J. E., & Karavolas, H. J. (1980). Pituitary 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases. J. Biol. Chem., 255, 11807-11814.
50. A receptor function. Trends Pharmacol. Sci., 16, 295-303.
51. A receptor regulation by a chloride-dependent kinase and a sodium-dependent phosphatase. Mol. Brain Res., 20, 192-198.
52. A receptor modulators. Am. J. Physiol. 271, E763-E772.
53. Legrain, A., Berr, C., Frenoy, N., Gourlet, V., Debuire, B., & Baulieu, E. E. (1995). Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology, 41, 343-351.
54. Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science, 232, 1004-1007.
55. A receptor. Mechanism of action and physiological significance. Prog. Neurobiol., 38, 379-395.
56. A receptor. Brain Res., 526, 143-146.
57. Majewska, M. D., Mienville, J.-M., & Vicini, S. (1988). Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci. Lett., 90, 279-284.
58. A receptor complex in the rat. J. Pharmacol. Exp. Ther., 275, 1412-1417.
59. McEwen, B. S. (1991). Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci., 12, 141-147.
60. Melcangi, R. C., Celotti, F., Castano, P., & Martini, L. (1993). Differential localization of the 5α-reductase and the 3α-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology, 132, 1252-1259.
61. Mellon, S. H. (1994). Neurosteroids: biochemistry, modes of action and clinical relevance. J. Clin. Endocrinol. Metab., 78, 1003-1008.
62. Mellon, S. H., & Dschepper, C. F. (1993). Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res., 629, 283-292.
63. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. U.S.A., 92, 3774-3778.
64. Morrow, A. L., Pace, J. R., Purdy, R. H., & Paul, S. M. (1990). Characterization of steroid interactions with γ-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol. Pharmacol., 37, 263-270.
65. Näsman, B., Olsson, B., Bäckström, T., Erikson, S., Grankvist, K., Viitanen, M., & Bucht, G. (1991). Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry, 30, 684-690.
66. Nemeroff, C. B., Widerlöv, E., Bisette, G., Walleus, H., Kartsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984). Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science, 226, 1342-1343.
67. A receptors. FASEB J., 4, 1469-1480.
68. Patchev, V. K., Shoaib, M., Holsboer, F., Almeida, O. F. X. (1994). The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neurosci., 62, 265-271.
69. Patchev, V. K., Holsboer, F., Almeida, O. F. X. (1996). The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15, 533-541.
70. Paul, S. M., & Purdy, R. H. (1992). Neuroactive steroids. FASEB J., 6, 2311-2322.
71. Power, R. F., Mani, S. K., Codina, J., Conneely, O. M., & O'Malley, B. W. (1991). Dopaminergic and ligand-independent activation of steroid hormone receptors. Science, 254, 1636-1639.
72. A receptor-complex. Neurosci. Lett., 135, 273-275.
73. A receptors. Neuron, 4, 759-765.
74. Purdy, R. H., Morrow, A. L., Blinn, J. R., Paul, S. M. (1990). Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptosomes. J. Med. Chem., & 33, 1572-1581.
75. Purdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991). Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U.S.A., 8, 4553-4557.
76. Richards, C. D., & Hesketh, T. R. (1975). Implications for theories of anaesthesia of antagonism between anaesthetic and non-anaesthetic steroids. Nature, 256, 179-182.
77. Rodriguez-Sierra, J. F., Hagley, M. T., & Hendricks, S. E. (1986). Anxolytic effects of progesterone are sexually dimorphic. Life Sci., 38, 1841-1845.
78. Romeo, E., Auta, J., Kozikowski, A., Papadopoulos, V., Puia, G., Costa, E., & Guidotti, A. (1992). 2-Arylindole-3-acetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Ther., 262, 971-978.
79. Romeo, E., Brancati, A., De Lorenzo, A., Fucci, P., Furnari, C., Pompili, E., Sasso, G. F., Spalletta, G., Troisi, A. & Pasini, A. (1996). Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin. Neuropharmacol., 19, 366-369.
80. Rupprecht, R., Reul, J.M.H.M., Trapp, T., van Steensel, B., Wetzel, C., Damm, K., Zieglgänsberger, W., & Holsboer, F. (1993). Progesterone receptor-mediated effects of neuroactive steroids. Neuron, 11, 523-530.
81. Rupprecht, R., Berning, B., Hauser, C. A. E., Holsboer, F., & Reul, J.M.H.M. (1996). Steroid receptor mediated effects of neuroactive steroids: characterization of structure-activity relationship. Eur. J. Pharmacol., 303, 227-234.
82. Sarrieau, A., Dussaillant, M., Agid, F., Philibert, D., Agid, Y., & Rostene, W. (1986). Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain. J. Steroid Biochem., 25, 717-721.
83. Schmidt, P. J., Purdy, R. H., Moore, P. H., Paul, S. M., & Rubinow, D. R. (1994). Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J. Clin. Endocrinol. Metab., 79, 1256-1260.
84. Sunderland, T., Merill, C. R., Harrington, M. G., Lawlor, B. A., Molchan, S. E., Martinez, R., & Murphy, D. L. (1989). Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet, 2, 570.
85. Schweizer, E., Case, W. G., Garcia-Espana, F., Greenblatt, D. J., & Rickels, K. (1995). Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome. Psychopharmacology, 117, 424-429.
86. A receptor family: molecular and functional diversity. Cold Spring Harb. Symp., 50, 29-40.
87. Selye, H. (1941). The anesthetic effect of steroid hormones. Proc. Soc. Exp. Biol Med., 46, 116-121.
88. A receptor on the response to a neurosteroid. Eur. J. Pharmacol., 206, 77-80.
89. A receptor subtype. Brain Res. Bull., 23, 317-322.
90. A-receptor modulation. Brain Res., 615, 267-274.
91. Thomas, G., Frenoy, N., Legrain, S., Sebag-Lanoe, R., Baulieu, E. E., & Debuire, B. (1994). Serum dehydroepiandrosterone sulfate levels as an individual marker. J. Clin. Endocrinol. Metab., 79, 1273-1276.
92. Ungerer, A., Mathis, C., Mélan, C., & De Barry, J. (1991). The NMDA receptor, CPP and γ-L-glutamyl-L-aspartate selectively block post training improvement of performance in a Y-maze avoidance learning task. Brain Res., 549, 59-65.
93. Wieland, S., Belluzi, J. D., Stein, L., Lan, N. C. (1995). Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents. Psychopharmacology, 118, 65-71.
94. Wieland, S., Lan, N. C., Mirasedeghi, S., & Gee, K. W. (1991). Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res., 565, 263-268.
95. Wu, F.-S., Gibbs, T. T., & Farb, D. H. (1990). Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone. Mol. Pharmacol., 37, 597-602.
96. Wu, F.-S., Gibbs, T. T., & Farb, D. H. (1993). Pregnenolone sulfate: a positive allosteric modulator at the N-Methyl-D-aspartate receptor. Mol. Pharmacol., 40, 333-336.